
Pediatric Conduits

Femoral Vein vs. PTFE Graft: Stage I Norwood1
For patients receiving a Femoral Vein:
- Better growth and development of branch pulmonary arteries
- Improved Nakata Index
- No recognizable adverse events with tissue
Variable | Valved Femoral Vein Homograft (n=14) |
Gore-Tex Graft (n=34) |
p=Value (<0.05) |
---|---|---|---|
Age of pre Glenn (weeks) | 16.55 ± 4.34 | 14.59 ± 3.45 | NS |
Nakata Index | |||
at birth | 110.19 ± 45.64 | 83.8 ± 23.67 | NS |
at pre Glenn | 364.84 ± 299.13 | 162.46 ± 74.5 | 0.02 |
PA size (mm) | |||
RPA | 7.81 ± 3.62 | 5.05 ± 1.19 | 0.02 |
LPA | 7.22 ± 2.07 | 5.66 ± 1.96 | 0.03 |
PA growth velocity (mm/week) | |||
RPA | 0.22 ± 0.16 | 0.13 ± 0.07 | 0.03 |
LPA | 0.2 ± 0.12 | 0.17 ± 0.11 | NS |
Saphenous Vein vs. ePTFE Graft: Stage I Norwood2
For patients receiving a Saphenous Vein:
- Better RV systolic function pre-Glen
- No regurgitation or functional deterioration with tissue

Ordering Information
Catalogue Number | Size Range |
---|---|
PCFV00 – Femoral Vein Allograft without Competent Valve PCFV10 – Femoral Vein Allograft with Competent Valve |
Diameter: 4mm+ OD Length: 12cm-16cm |
PCSV00 – Saphenous Vein Allograft without Competent Valve PCSV10 – Saphenous Vein Allograft with Competent Valve |
Diameter: 3mm+ OD Length: 12cm-16cm |
Place an order or ask technical questions any time (24 hours, 365 days a year)
by calling 1-888-427-9654.
References
- Briceno-Medina M, et al. Poster presentation at 2016 Western Thoracic Surgical Society Annual Meeting.
- Takeuchi K, et al. Interactive Cardiovasc and Thorac Surg, 2006; 5:345-348.
Cardiac Allografts